Ratio of vaccination against pneumococcus was found to be higher among the patients who had vaccination cards (p
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Aim: The aim of the present study is to investigate the factors which influence vaccination status against seasonal influenza and pneumococcus in patients with sickle cell anemia which is known to be the most common hereditary hematologic disease worldwide.
📊
Key Findings & Data:Materials and Methods: This prospective, cross-sectional study was conducted with the volunteer patients above 18 years who were admitted to Hematology Clinic of Baskent University Adana Research and Training Center due to sickle cell anemia during 01 December – 31 December 2018.
💡
Conclusion & Impact:Ratio of vaccination against pneumococcus was found to be higher among the patients who had vaccination cards (p
🔬Design:Research Article
📍Scope:2018 Verileri
⚙️Variables:Domain Parameters
Abstract
Aim: The aim of the present study is to investigate the factors which influence vaccination status against seasonal influenza and pneumococcus in patients with sickle cell anemia which is known to be the most common hereditary hematologic disease worldwide. Materials and Methods: This prospective, cross-sectional study was conducted with the volunteer patients above 18 years who were admitted to Hematology Clinic of Baskent University Adana Research and Training Center due to sickle cell anemia during 01 December – 31 December 2018. Results: Of 38 patients, 22 (57.9%) were females. Ratio of vaccination against pneumococcus was found to be higher among the patients who had vaccination cards (p
🔖
Cite This Article
ASMA, S., KORUR, A., GEREKLİOĞLU, Ç., ÖZDOĞU, H., BOĞA, C. (2022). Factors influencing vaccination status against influenza and pneumococcus in sickle cell anemia patients. Annals of Medical Research, Cilt: 28 - Sayı: 2, 343–346. https://ajindex.com/articles/445757
Hassell KL. Population estimates of sickle cell disease in the U.S. Am J Prev Med 2010;38:512-21
Sheth S, Licursi M, Bhatia M. Sickle cell disease: time for a closer look at treatment options? Br J Haematol 2013;162:455-64
Karacaoglu PK, Asma S, Korur A, et al. East Mediterranean region sickle cell disease mortality trial: retrospective multicenter cohort analysis of 735 patients. Ann Hematol 2016;95:993-1000
Elmariah H, Garrett ME, De Castro LM, et al. Factors associated with survival in a contemporary adult sickle cell disease cohort. Am J Hematol 2015;89:530-5
Galarneau G, Coady S, Garrett ME, et al. Gene-centric association study of acute chest syndrome and painful crisis in sickle cell disease patients. Blood 2013;122:434-42
Sandhu MK, Cohen A. Aging in sickle cell disease: co-morbidities and new issues in management. Hemoglobin 2015;39:221-4
Galloway-Blake K, Ried M, Walters C, et al. Clinical factors associated with morbidity and mortality in patients admitted with sickle cell disease. West Indian Med J 2014;63:711-6
Booth C, Inusa B, Obaro SK. Infection in sickle cell disease: a review. International Journal of Infectious Diseases 2010;14:2-12
Korur A, Asma S, Gereklioglu C, et al. Significance of electronic health records: A comparative study of vaccination rates in patients with sickle cell disease. Pak J Med Sci 2017;33:549-53
Wiyeh AB, Abdullahi LH, Wonkam A, et al. Effects of vaccines in patients with sickle cell disease: a systematic review protocol. BMJ open 2018;8: e021140
Alpay Y, Ağalar C. Erişkin Bağışıklama. FLORA 2016;21:95-104
Gorham MW, Smith CR, Smith SK, et al. Vaccinations in sickle cell disease: An audit of vaccination uptake in sickle cell patients attending Newham University Hospital. Vaccine 2015;33:5005-11
Ozdogu H, Boga C, Yeral M, et al. Allogenic peripheral stem cell transplantation from HLA-matched related donors for adult sickle cell disease: remarkable outcomes from a single-center trial. Bone Marrow Transplant 2018;53:880-90